SLE initially presenting with neuropsychiatric manifestations and seizure, case report
© 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd..
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder exhibiting variable disease courses and multiple clinical manifestations. SLE's aetiology remains unclear; however, different environmental (e.g., ultraviolet light, infections, drugs, etc.), genetic, and hormonal factors are potentially involved. A positive family history and history of having other autoimmune illnesses are considered high-risk factors for SLE; nevertheless, most SLE cases are scattered. The 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for SLE include at least one positive antinuclear antibody test as a mandatory entry criterion, followed by additive weighted standards grouped in seven clinical (constitutional, haematological, neuropsychiatric, serosal, musculoskeletal, renal, and mucocutaneous) and three immunological (antiphospholipid antibodies, complement proteins, and SLE-specific antibodies) domains weighted from 2 to 10, with patients accumulating ≥10 points being diagnosed with SLE. Herein, we report a case of neuropsychiatric lupus, a rare and severe form of SLE.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Immunity, inflammation and disease - 11(2023), 6 vom: 20. Juni, Seite e918 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Khormi, Abdulrahman Ali M [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antibodies |
---|
Anmerkungen: |
Date Completed 30.06.2023 Date Revised 02.07.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.1002/iid3.918 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM35883550X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM35883550X | ||
003 | DE-627 | ||
005 | 20231226075606.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/iid3.918 |2 doi | |
028 | 5 | 2 | |a pubmed24n1196.xml |
035 | |a (DE-627)NLM35883550X | ||
035 | |a (NLM)37382262 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Khormi, Abdulrahman Ali M |e verfasserin |4 aut | |
245 | 1 | 0 | |a SLE initially presenting with neuropsychiatric manifestations and seizure, case report |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 30.06.2023 | ||
500 | |a Date Revised 02.07.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd. | ||
520 | |a Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder exhibiting variable disease courses and multiple clinical manifestations. SLE's aetiology remains unclear; however, different environmental (e.g., ultraviolet light, infections, drugs, etc.), genetic, and hormonal factors are potentially involved. A positive family history and history of having other autoimmune illnesses are considered high-risk factors for SLE; nevertheless, most SLE cases are scattered. The 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for SLE include at least one positive antinuclear antibody test as a mandatory entry criterion, followed by additive weighted standards grouped in seven clinical (constitutional, haematological, neuropsychiatric, serosal, musculoskeletal, renal, and mucocutaneous) and three immunological (antiphospholipid antibodies, complement proteins, and SLE-specific antibodies) domains weighted from 2 to 10, with patients accumulating ≥10 points being diagnosed with SLE. Herein, we report a case of neuropsychiatric lupus, a rare and severe form of SLE | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a autoimmunity | |
650 | 4 | |a blood | |
650 | 4 | |a diseases | |
650 | 4 | |a systemic lupus erythematosus | |
650 | 4 | |a tissues | |
650 | 7 | |a Antibodies |2 NLM | |
700 | 1 | |a Hijazi, Faisal Taher |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Immunity, inflammation and disease |d 2013 |g 11(2023), 6 vom: 20. Juni, Seite e918 |w (DE-627)NLM243574827 |x 2050-4527 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2023 |g number:6 |g day:20 |g month:06 |g pages:e918 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/iid3.918 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2023 |e 6 |b 20 |c 06 |h e918 |